Research Article
[Retracted] Clinical Efficacy of Osimertinib in Patients with Advanced Non-Small Cell Lung Cancer and Its Effect on Serum CEA and VEGF Expression
Table 1
Comparison of baseline data (n (%)).
| | Conventional group (n = 40) | Experimental group (n = 40) | t or x2 | value |
| Gender | Male | 24 | 26 | 0.213 | 0.644 | Female | 16 | 14 |
| Mean age (year) | 66.87 ± 5.34 | 66.93 ± 5.36 | −0.05 | 0.96 | Smoking | Yes | 27 | 28 | 0.058 | 0.809 | No | 13 | 12 |
| TNM staging | IIIA | 18 | 20 | 0.075 | 0.785 | IIIB | 13 | 12 | IV | 9 | 8 |
| Pathological type | Adenocarcinoma | 37 | 38 | 0.213 | 0.644 | Adenosquamous carcinoma | 3 | 2 |
|
|